The fellowship training program in Pediatric Hematology/Oncology is fully accredited by the Residency Review Committee for Pediatrics of the Accreditation Council for Graduate Medical Education. It is a three year program but may extend beyond this depending on the individual needs of the trainee. We are committed to excellent clinical care and management of children with cancer and diseases of the blood. The trainee will have experience in all aspects of the sub-specialty by direct patient contact and support from our faculty. Clinical areas of training include the leukemias, solid tumors, brain tumors, hematopoietic/stem cell transplantation, general pediatric hematology, sickle cell disease, bone marrow failure syndromes, hemophilia and other coagulation disorders.
The bulk of this clinical training will occur in the first year of the fellowship. There will be three to four months of inpatient hematology/oncology service, three months on the Hematology/Oncology Consultative Service, three months on the Pediatric Stem Cell Transplant Service, one month devoted to aspects of radiation oncology, blood banking, hemostasis and hematopathology and one month of elective time to help prepare for clinical or basic science investigation that will be the focus during the next two to three years. Throughout the fellowship years, trainees will spend approximately one day/week seeing patients in the outpatient setting. Call will average every sixth night and weekend.
The second and third years of training are designed to prepare the trainee for clinical or laboratory investigation. Opportunities for investigation within the Section of Hematology/Oncology, the Herman B Wells Center for Pediatric Research, Riley Hospital and Indiana University School of Medicine are excellent and broadly based.
Fellows are encouraged to participate in two unique opportunities for training in clinical research at Indiana University: the Institute for Informatics and the federally funded Clinical Investigator Training Enhancement (CITE) program.